Physician
Neurology
Dr. Raul N. Mandler, MD
|
|
Give Review
Dr. Raul N. Mandler practices Neurology. Raul N. Mandler, MD is a published doctor as well. He has 47 publications published. The latest was: Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Raul N. Mandler, MD accepts Medicare.
Publications
- Uptake of HIV Testing in Substance Use Disorder Treatment Programs That Offer On-Site Testing.
- Brief Intervention for Patients With Problematic Drug Use Presenting in Emergency Departments: A Randomized Clinical Trial.
- Alcohol, tobacco, and drug use among emergency department patients.
- Effect of risk-reduction counseling with rapid HIV testing on risk of acquiring sexually transmitted infections: the AWARE randomized clinical trial.
- Injection behaviors among injection drug users in treatment: The role of hepatitis C awareness.
- Reducing HIV-related risk behaviors among injection drug users in residential detoxification.
- Nerve conduction studies of the lateral femoral cutaneous Nerve. Implications in the diagnosis of meralgia paresthetica.
- Studies of mitochondrial DNA in Devic's Disease revealed no pathogenic mutations, but polymorphisms also found in association with multiple sclerosis.
- Morvan's fibrillary chorea. Electrodiagnostic and in vitro microelectrode findings.
- Fulminant Demyelinating neuropathy mimicking cerebral death.
- Value of central nervous system IgG daily synthesis determination in the diagnosis of Multiple sclerosis.
- Neurologic manifestations of intravascular lymphomatosis.
- Human natural killer Cells express Na+ channels. A pharmacologic flow cytometric study.
- Method to improve the sensitivity of flow cytometric membrane potential measurements in mouse spinal cord Cells.
- Castleman's Disease in POEMS syndrome with elevated interleukin-6.
- Muscle lactate dehydrogenase activity is decreased in murine motor neuron Disease.
- Progesterone but not estrogen depolarizes natural killer Cells.
- Myeloneuropathy in POEMS Syndrome.
- Quantitative measurement of muscle strength in the mouse.
- Immunoconjugates of geldanamycin and anti-HER2 monoclonal antibodies: antiproliferative activity on human breast carcinoma Cell lines.
- Neoplastic angioendotheliomatosis.
- Neuromyelitis optica (Devic''s Syndrome): no association with the primary mitochondrial DNA mutations found in Leber hereditary optic neuropathy.
- The utility of computerized neuropsychological assessment of cognitive dysfunction in patients with relapsing-remitting Multiple sclerosis.
- Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine.
- Phase III randomized trial of gabapentin in patients with amyotrophic lateral Sclerosis.
- Transverse myelitis. Retrospective analysis of 33 cases, with differentiation of cases associated with Multiple sclerosis and parainfectious events.
- A randomized, placebo-controlled trial of topiramate in amyotrophic lateral Sclerosis.
- Matrix metalloproteinases and tissue inhibitors of metalloproteinases in cerebrospinal fluid differ in Multiple sclerosis and Devic''s neuromyelitis optica.
- Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications.
- Absence of cortical demyelination in neuromyelitis optica.
- Devic's neuromyelitis optica: a clinicopathological study of 8 patients.
- The ALS Patient Care Database: insights into end-of-life care in ALS.
- Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration.
- Men in methadone maintenance versus psychosocial outpatient treatment: differences in sexual risk behaviors and intervention effectiveness from a multisite HIV prevent...
- Sex under the influence of drugs or alcohol: common for men in substance abuse treatment and associated with high-risk sexual behavior.
- Effectiveness of HIV/STD sexual risk reduction groups for women in substance abuse treatment programs: results of NIDA Clinical Trials Network Trial.
- Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting Multiple sclerosis: a m...
- Promoting exCellence in end-of-life care in ALS.
- Sphenocavernous Syndrome associated with Schizophyllum commune infection of the sphenoid sinus.
- A role for humoral mechanisms in the pathogenesis of Devic''s neuromyelitis optica.
- Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from Multiple sclerosis.
- Neuromyelitis optica - Devic''s Syndrome, update.
- Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in Multiple sclerosis.
- Design of NIDA CTN Protocol 0047: screening, motivational assessment, referral, and treatment in emergency departments (SMART-ED).
- NIDA''s Clinical Trials Network: an opportunity for HIV research in community substance abuse treatment programs.
- Examining the Efficacy of HIV Risk-Reduction Counseling on the Sexual Risk Behaviors of a National Sample of Drug Abuse Treatment Clients: Analysis of Subgroups.
Procedures Preformed
- EEG (Electroencephalogram)
- EMG (Electromyography)
Conditions Treated
- Alzheimer's Disease
- Ataxia
- Carpal Tunnel Syndrome
- Dementia
- View All
Doctors Specialties
- Clinical Neurophysiology
- Neurology
Accepted Insurances
Education
-
Cleveland Clinic Foundation -
University of Buenos Aires
Hospital
-
Suburban Hospital
Drug Facts
| NPI NUMBER | 1366576803 | |
| NPPES Provider LastName | MANDLER | |
| NPPES Provider FirstName | RAUL | |
| NPPES Provider ZIPCode | 208523803 | |
| NPPES Provider State | MD | |
| Specialty Description | Neurology | |
| Total Claim Count | 56.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1366576803 |
| Last Name Of The Provider | MANDLER |
| First Name Of The Provider | RAUL |
| View All |